Organisational hazards when treating patients with cytotoxic drugs

Forskningsoutput: Tidskriftsbidrag › Publicerat konferensabstract

Standard

Organisational hazards when treating patients with cytotoxic drugs. / Ternov, Sven; Fyhr, AnnSofie; Akselsson, Roland.

I: EJC Supplements, Vol. 7, Nr. 2, 2009, s. 210-210.

Forskningsoutput: Tidskriftsbidrag › Publicerat konferensabstract

Harvard

Ternov, S, Fyhr, A & Akselsson, R 2009, 'Organisational hazards when treating patients with cytotoxic drugs', EJC Supplements, vol. 7, nr. 2, s. 210-210.

APA

Ternov, S., Fyhr, A., & Akselsson, R. (2009). Organisational hazards when treating patients with cytotoxic drugs. EJC Supplements, 7(2), 210-210.

CBE

Ternov S, Fyhr A, Akselsson R. 2009. Organisational hazards when treating patients with cytotoxic drugs. EJC Supplements. 7(2):210-210.

MLA

Ternov, Sven, AnnSofie Fyhr, och Roland Akselsson. "Organisational hazards when treating patients with cytotoxic drugs". EJC Supplements. 2009, 7(2). 210-210.

Vancouver

Ternov S, Fyhr A, Akselsson R. Organisational hazards when treating patients with cytotoxic drugs. EJC Supplements. 2009;7(2):210-210.

Author

Ternov, Sven ; Fyhr, AnnSofie ; Akselsson, Roland. / Organisational hazards when treating patients with cytotoxic drugs. I: EJC Supplements. 2009 ; Vol. 7, Nr. 2. s. 210-210.

RIS

TY - JOUR

T1 - Organisational hazards when treating patients with cytotoxic drugs

AU - Ternov, Sven

AU - Fyhr, AnnSofie

AU - Akselsson, Roland

PY - 2009

Y1 - 2009

M3 - Published meeting abstract

VL - 7

SP - 210

EP - 210

JO - European Journal of Cancer Supplements

JF - European Journal of Cancer Supplements

SN - 1359-6349

IS - 2

T2 - 15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology

Y2 - 20 September 2009 through 24 September 2009

ER -